Structural and Functional Insights Into Lyn Kinase: From Immune Regulation to Therapeutic Targeting
Journal of Cellular Biochemistry · 2026
DOI: 10.1002/jcb.70082 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Cellular Biochemistry, 2026. Verfasst von Alisha Khan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, School of Chemical and Life Sciences, Jamia Hamdard, Hamdard Nagar, New Delhi, India. Hauptthemen laut MEDLINE: src-Family Kinases, Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 243 Literaturangaben. Gefördert von: Central Council for Research in Unani Medicine (CCRUM).
Abstract (Originalsprache)
Lyn kinase, a member of the Src family of kinases, is a critical regulator of immune cell signaling, regulating key processes including activation, proliferation, survival, and apoptosis. Dysregulated Lyn kinase activity causes haematological malignancies, autoimmune disorders, solid tumors, neurodegenerative, cardiovascular, and metabolic disorders. Here, we aimed to provide a comprehensive account of Lyn kinase biology, highlighting its structural features, regulatory roles in immune and cellular signaling, and pathological implications across diseases, including cancers, neurodegenerative disorders, autoimmune diseases, and metabolic disorders. We further examined emerging therapeutic strategies, including small‐molecule inhibitors, monoclonal antibodies, and natural compounds, and highlighted the therapeutic potential of Lyn kinase as a promising drug target. Overexpression of Lyn contributes to tumor growth, metastasis, and resistance to treatment in leukaemia, prostate, breast, lung, and pancreatic cancers. Beyond oncology, emerging evidence links Lyn kinase to neuroinflammation, synaptic dysfunction, and metabolic regulation, further underscoring its broad disease relevance. Lyn kinase is considered a viable therapeutic target, with ongoing research focusing on small‐molecule inhibitors, monoclonal antibodies, and natural compounds like flavonoids and polyphenols that have exhibited promising preclinical and clinical outcomes. We summarized current insights into Lyn kinase biology, highlighting its pathological significance and discussing therapeutic opportunities arising from the modulation of this enzyme.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biotechnology, School of Chemical and Life Sciences, Jamia Hamdard, Hamdard Nagar, New Delhi, India.
- Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi, India.
- Department of Basic Medical Science, College of Medicine, Prince Sattam Bin Abdulaziz University, Al-Kharj, Saudi Arabia.
ORCID-Profile: Md Imtaiyaz Hassan
Förderung
- Central Council for Research in Unani Medicine (CCRUM)
Zitieren
APA
Khan, A., Taiyab, A., Hasan, G. M., Wajid, S., & Hassan, M. I. (2026). Structural and Functional Insights Into Lyn Kinase: From Immune Regulation to Therapeutic Targeting. Journal of Cellular Biochemistry. https://doi.org/10.1002/jcb.70082
Vancouver
Khan A, Taiyab A, Hasan GM, Wajid S, Hassan MI. Structural and Functional Insights Into Lyn Kinase: From Immune Regulation to Therapeutic Targeting. Journal of Cellular Biochemistry. 2026. doi:10.1002/jcb.70082
BibTeX
@article{Khan2026,
author = {Khan, Alisha and Taiyab, Aaliya and Hasan, Gulam Mustafa and Wajid, Saima and Hassan, Md Imtaiyaz},
title = {Structural and Functional Insights Into Lyn Kinase: From Immune Regulation to Therapeutic Targeting},
journal = {Journal of Cellular Biochemistry},
year = {2026},
doi = {10.1002/jcb.70082}
}
EUVIMED